Medical disclaimer. This page is for tracking and education only. It is not medical advice and it never recommends doses. Talk with your prescriber or care team before you change, lower, or stop any medication. Ozempic, Wegovy, Mounjaro, and Zepbound are named only to describe what readers search for.
Start with your prescriber
Coming off Ozempic is a medication decision that belongs with your prescriber or care team. If you are thinking about stopping, pausing, or changing a GLP-1, the safest first step is to ask for a visit and talk through your full plan, including follow-up.
People often search for coming off Ozempic because they want to know what may happen next. The honest answer is that responses vary. Some people notice appetite changes, weight changes, or changes in how they feel day to day. Others want help organizing their questions before the appointment. A simple note with your current medication history, recent weight trend, appetite changes, and any side effects can make that conversation easier.
If eating feels hard, if you are worried about being able to keep up with meals, or if you have a history of disordered eating, tell your clinician. This is a good time to ask for individualized guidance rather than trying to interpret your own experience in isolation.
If you want a plain-language overview of what people may notice after stopping, see what happens when you stop a GLP-1.
What trials report after stopping a GLP-1
Research gives a clearer picture than internet anecdotes, but it still does not tell any one person exactly what will happen. In the STEP 1 extension of semaglutide 2.4 mg, participants had lost 17.3% of body weight by week 68. A year after stopping, they had regained 11.6 percentage points of that loss, about two thirds.
In the SURMOUNT-4 trial, adults who completed 36 weeks of tirzepatide and were then switched to placebo gained 14.0% of body weight from week 36 to week 88, while those who continued tirzepatide lost a further 5.5%.
These results do not mean the same thing will happen to every adult who searches for coming off Ozempic. They do show why many clinicians prefer follow-up after any GLP-1 change. Weight, appetite, and routine can all shift over time, and it can help to know what your prescriber wants you to watch for.
If you are reading about tapering, be careful with advice that sounds one size fits all. A taper is a medical decision, and people should not copy someone else’s plan. For a broader explanation of why tapering questions come up, see GLP-1 taper schedule.
What to track while you wait for answers
You do not need a perfect system. A short weekly record can help you notice patterns and bring clearer information to your next visit. The goal is tracking, not self-judgment.
- Weight trend over time, not one day at a time
- Appetite level and whether food feels quiet or loud
- Strength sessions or other exercise you are already doing
- Protein and fiber habits if you already track them
- Sleep, stress, and anything else that seems linked to appetite or routine
- Any side effects or changes you want to remember for your clinician
Some people also like to note when they feel more settled or more distracted around meals. If eating feels hard, talk to a clinician rather than trying to solve it alone. Tracking is meant to support care, not replace it.
The app is planned to include a weekly appetite check-in from 1, quiet, to 5, loud, along with a weekly weight trend, strength log, and simple target tracking based on the body weight information you enter. It will not calculate, validate, or suggest medication doses. If you want to understand how the timeline view works, see taper timeline.
Questions to bring to your visit
A short list can make the appointment more useful. You can bring the questions that matter most to you and cross out the ones you do not need.
- What should I watch for after coming off Ozempic?
- What follow-up schedule do you want for me?
- Which changes should prompt me to contact your office?
- How should I track weight, appetite, or exercise between visits?
- If eating feels harder, who should I contact?
- Do you want me to bring a record of my weight trend or symptoms?
You can also ask whether any planned medication change should be documented in a certain way so your records stay clear. If you have questions about goals, timing, or next steps, the prescriber can explain what fits your health history.
Where the app fits
Ballast is planned as a reference and tracking app for adults who are tapering, have stopped, or are maintaining after a GLP-1 medication. It is not a medical service and it will not tell you what to do with your medication.
The app is designed to keep the useful parts simple: a weekly weight trend, an adjustable regain band, protein and fiber targets from the body weight you enter, a strength log that aims to help you keep track of 2 to 3 sessions a week, a taper timeline that only records dose steps you type in, and a weekly appetite check-in. Data is stored on the device, with no account, and you can export and delete everything.
If you like having your notes in one place, the app may help you organize the questions and measurements you want to discuss with your clinician. It will also include a medical disclaimer and a free tier with an optional Pro subscription. For a deeper look at the tracking approach, you can read about what happens when you stop a GLP-1 and the planned taper timeline.
Join the iOS waitlist from Get the app.
Key facts
- In the STEP 1 extension (2022), people regained 11.6 of the 17.3 percentage points they had lost, about two thirds, within a year of stopping semaglutide. Source
- In SURMOUNT-4 (JAMA 2024), from week 36 to week 88 people switched to placebo gained 14.0% of body weight, while those who continued tirzepatide lost a further 5.5%. Source
Sources
Last updated: